{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-060689","form_type":"8-K","ticker":"GRDX","cik":"0001604191","company_name":"GridAI Technologies Corp.","filed_at":"2024-05-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.183870+00:00","generated_at":"2026-06-02T02:21:32.557823+00:00","sec_items":["1.01","3.02","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"First Wave BioPharma raises ~$1.1M in registered direct offering priced at $2.95/share","bullets":["Gross proceeds expected ~$1.1M; net proceeds ~$0.9M after agent fees.","Offering includes 366,000 shares/pre-funded warrants at $2.95 and warrants for 732,000 shares at $2.70.","Warrants are immediately exercisable, 6-year term, exercise price $2.70.","Proceeds to be used for working capital and general corporate purposes.","Closing expected on or about May 14, 2024, subject to customary conditions."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-060689","json":"https://secwatch.observer/filing/0001104659-24-060689.json","markdown":"https://secwatch.observer/filing/0001104659-24-060689.md","text":"https://secwatch.observer/filing/0001104659-24-060689.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1604191/000110465924060689/0001104659-24-060689-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1604191/000110465924060689/tm2414315d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-02T02:21:32.557823+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"839e76bf8092ec375cfbedac335957f80f9e001c","claim":"GridAI Technologies Corp. entered into Purchase Agreement with certain purchasers valued at approximately $0.9 million (effective 2024-05-10).","evidence_excerpt":"On May 10, 2024, First Wave BioPharma, Inc. (the “Company”) entered into a placement agency agreement (the “Placement Agency Agreement”) with Roth Capital Partners, LLC (the “Placement Agent”) and a securities purchase agreement (the “Purchase Agreement”) with certain purchasers","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1604191/000110465924060689/0001104659-24-060689-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"certain purchasers"},{"label":"Value","value":"approximately $0.9 million"},{"label":"Effective","value":"2024-05-10"}],"fact_type":"material_agreement"},{"claim_id":"bdeb8bfb37d6e1b624cb01417d51b399ab30ae17","claim":"GridAI Technologies Corp. entered into Placement Agency Agreement with Roth Capital Partners, LLC (effective 2024-05-10).","evidence_excerpt":"On May 10, 2024, First Wave BioPharma, Inc. (the “Company”) entered into a placement agency agreement (the “Placement Agency Agreement”) with Roth Capital Partners, LLC (the “Placement Agent”)","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1604191/000110465924060689/0001104659-24-060689-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"underwriting"},{"label":"Counterparty","value":"Roth Capital Partners, LLC"},{"label":"Effective","value":"2024-05-10"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}